Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:: Both or neither?

被引:336
|
作者
Farinati, F [1 ]
Marino, D [1 ]
De Giorgio, M [1 ]
Baldan, A [1 ]
Cantarini, M [1 ]
Cursaro, C [1 ]
Rapaccini, G [1 ]
Del Poggio, P [1 ]
Di Nolfo, MA [1 ]
Benvegnù, L [1 ]
Zoli, M [1 ]
Borzio, F [1 ]
Bernardi, M [1 ]
Trevisani, F [1 ]
机构
[1] Univ Policlin Padua, Dept Surg & Gastroenterol Sci, I-35128 Padua, Italy
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 03期
关键词
D O I
10.1111/j.1572-0241.2006.00443.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: The clinical usefulness of alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC) management is debatable. OBJECTIVES: To assess, in a large multi-centric survey, diagnostic and prognostic reliability of AFP, predictive factors, and any correlation with the tumor immunophenotype. METHODS: A total of 1,158 patients with HCC were analyzed with reference to serum AFP levels at diagnosis. We evaluated: HCC grading, histotype, and size; Okuda, tumor-nodes-metastases (TNM), and Child-Pugh scores; liver function, symptoms, presence of metastases or portal thrombosis, etiology, survival, and treatment. In 66 patients with histological diagnosis, the pathologists evaluated p53 overexpression, MIB 1 labeling index, BCL-2 positive cells (index of apoptosis), and CD44 (adhesion molecule) positivity. RESULTS: Patients were divided into three AFP groups: normal (< 20 ng/mL) [46%], elevated (21-400 ng/mL) [36%], and diagnostic (> 400 ng/mL) [18%]. Statistical correlations were significant for: weight loss (p= 0.0056), pain (p= 0.0025), Child-Pugh score (p= 0.001), tumor size, Okuda's and TNM stages, metastases, thrombosis, type of treatment (all p < 0.0001), and female sex (p < 0.004). AFP correlated with survival overall, in patients untreated, transplanted, or undergoing locoregional treatments; but not in those surgically treated. In the discriminant analysis, the related variables were size, female sex, Child-Pugh score, TNM staging (steps 1-4). When using the receiver operating characteristic curve, the prognostic reliability of AFP was limited with area under the curve of 0.59. Finally, patients with low expression of BCL2 had high AFP levels (p < 0.05). AFP positively correlated with Edmonson score (p < 0.0001). CONCLUSION: The evaluation of this large series of HCC patients allowed us to: confirm the low sensitivity (54%) of AFP in the diagnosis of HCC and its prognostic value, albeit limited, being tumor size, female sex (intriguingly enough), Child-Pugh score, and TNM staging independent predictors.
引用
收藏
页码:524 / 532
页数:9
相关论文
共 50 条
  • [31] The fucosylation index of α-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma
    Aoyagi, Y
    Isokawa, O
    Suda, T
    Watanabe, M
    Suzuki, Y
    Asakura, H
    [J]. CANCER, 1998, 83 (10) : 2076 - 2082
  • [32] The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients
    Silva, Jack P.
    Gorman, Richard A.
    Berger, Nicholas G.
    Tsai, Susan
    Christians, Kathleen K.
    Clarke, Callisia N.
    Mogal, Harveshp
    Gamblin, T. Clark
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (07) : 831 - 840
  • [33] Alpha-fetoprotein:A controversial prognostic biomarker for small hepatocellular carcinoma
    Mohamed Asrih
    Sébastien Lenglet
    Franois Mach
    Fabrizio Montecucco
    [J]. World Journal of Gastroenterology, 2013, (03) : 328 - 330
  • [34] Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance
    Li, Wei
    Liu, Kun
    Chen, Yi
    Zhu, Mingyue
    Li, Mengsen
    [J]. CURRENT MEDICINAL CHEMISTRY, 2021, 28 (06) : 1126 - 1142
  • [35] Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein
    Nouso, Kazuhiro
    Kobayashi, Yoshiyuki
    Nakamura, Shinichiro
    Kobayashi, Sayo
    Takayama, Hiroki
    Toshimori, Junichi
    Kuwaki, Kenji
    Hagihara, Hiroaki
    Onishi, Hideki
    Miyake, Yasuhiro
    Ikeda, Fusao
    Shiraha, Hidenori
    Takaki, Akinobu
    Iwasaki, Yoshiaki
    Kobashi, Haruhiko
    Yamamoto, Kazuhide
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (07) : 1195 - 1200
  • [36] The Immunosuppression Role of Alpha-fetoprotein in Human Hepatocellular Carcinoma
    Meng, Wenbo
    Li, Yan
    Bai, Bing
    Bai, Zhongtian
    Yue, Ping
    Li, Xun
    Qiao, Liang
    [J]. DISCOVERY MEDICINE, 2016, 21 (118) : 489 - 494
  • [37] Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma
    Johnson, PJ
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 : S32 - S36
  • [38] The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma
    Lu, Yan
    Lin, Bo
    Li, Mengsen
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [39] Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)
    Pozzan, Caterina
    Cardin, Romilda
    Piciocchi, Marika
    Cazzagon, Nora
    Maddalo, Gemma
    Vanin, Veronica
    Giacomin, Anna
    Pontisso, Patrizia
    Cillo, Umberto
    Farinati, Fabio
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (08) : 1637 - 1644
  • [40] Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
    Giannini, Edoardo G.
    Marenco, Simona
    Borgonovo, Giacomo
    Savarino, Vincenzo
    Farinati, Fabio
    Del Poggio, Paolo
    Rapaccini, Gian Ludovico
    Di Nolfo, Maria Anna
    Benvegnu, Luisa
    Zoli, Marco
    Borzio, Franco
    Caturelli, Eugenio
    Chiaramonte, Maria
    Trevisani, Franco
    [J]. HEPATOLOGY, 2012, 56 (04) : 1371 - 1379